about
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasisMelanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzymeHIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells.GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides.The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progressionTumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma.Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions.Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy.Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis.Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation.Metabolic reprogramming as a continuous changing behavior of tumor cells.Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.ENDOTHELIAL PROGENITOR CELLS AS SHUTTLE OF ANTICANCER AGENTS.CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells.TNFα receptor1 drives hypoxia-promoted invasiveness of human melanoma cells.The acidic microenvironment as a possible niche of dormant tumor cells.EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis.Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approachCancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness.EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells.Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis.Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in miceOrgan-specific metastases in melanoma: experimental animal models.Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms.Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells.Induction by human interferon and murine h-2l(d) gene of the surface expression of endogenous hla class-I free heavy-chains in hct human colon-carcinoma cells, deficient in Beta-2-microglobulin.Effect of phosphatidylcholine structure on the adenylate cyclase activity of a murine fibroblast cell line.Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B16 melanoma cells.Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.Lipid characteristics of RSV-transformed Balb/c 3T3 cell lines with different spontaneous metastatic potentials.Inhibition of lipoxygenase pathway in macrophages co-cultivated with tumor cells.Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells.Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.
P50
Q33291289-ECCAB80F-29FA-4B2A-AC5A-6B6E30DDC08DQ33967503-DF1573F9-B359-4960-B0C0-00C13C66E63BQ33977030-D8E9F93A-2C78-4E82-8FB1-B793546D6F75Q34195241-74349FD2-7D3C-42C8-9511-5A8ECBE54A9FQ34505275-51441B8A-C05D-4964-86D5-78321917DEB8Q36182260-B711C61D-3F9E-4970-8EAC-1EB083A6EAB4Q36780789-2BA2586D-B8AD-4607-8280-08E629ADCAAFQ37457696-699EA43A-CCC9-4153-AED6-B46B42CDDB9AQ37588253-7F56E63B-CD02-451C-9CA3-D5BD4F36D352Q37786019-AFFD02EB-9F2A-4497-A9B9-A563DC6F04DDQ38225316-087AE6DE-39FB-407E-B581-95A7A8D0E8FAQ38725276-301BC247-1A78-41C8-95A9-C5A2929B8058Q38766321-52B47DA4-EC27-4F92-9926-4F606D787D69Q38854843-6F316E61-9B7E-451E-B961-323B2D528C3DQ38908272-4CD0C306-D392-47C7-8D98-68EFA337B8A2Q38922167-542C3838-73B2-4913-BF96-48C3C35BED7DQ38983494-CBB52175-150B-4262-B702-B8DFA5D1B3B2Q39089201-0742DA93-9396-452D-B48D-FACFBD88E622Q39195025-523D3ACA-0F75-4F3A-BA62-69C7F31CC892Q39295109-39CF7B61-2768-47B5-9AF6-51600BC9B2F6Q39385429-08CF7534-1DD0-4610-8DD0-B0A0E2590415Q39542687-20380A75-DFFE-4E92-B95F-158EED89835DQ39607889-69FB4C69-894C-4305-AD46-71D47DE7C271Q39612340-D5D347D6-DF14-42FF-85B8-DF6C7A66A775Q39660946-BB7FD5ED-9DAD-442F-AFF5-F51B673B44A1Q39668916-DBF5D63B-C1B3-40D5-BDAA-55FAED46D6F5Q39793015-567BF886-870F-471A-BB93-F6A0C0EACC54Q40734616-ADE1A071-9DEB-472F-A86A-1C6273DC2596Q40771224-CB00BCE9-4DCC-4CCE-AE41-C84412D9F53DQ40926459-DD21896D-9E53-40C0-BDD1-4F8A7136127BQ41449363-B5D1EA7B-13BA-488A-B5EF-35B6FF3D90A4Q41535856-9ABFA31F-094B-42B1-8518-B03CF47FABC0Q41542155-38F25F65-FC8C-4F17-A392-96051F32FF72Q41559637-C7788C37-A08A-4097-820B-D932B7758CBBQ41862341-7D52B31E-44BA-4EC1-90B5-100CFDBF3F1AQ42045872-A9A73245-8E18-4CF3-BF5B-AA52AB85AF7BQ42796319-4597976B-F0C3-4D20-87B1-ED7F3A900FEAQ46487322-1E01BA09-B4AD-40C6-8F6A-BF9BE0EFCADAQ46974876-3C42AABF-B20C-4209-9AF7-2C58D3820288Q48031743-C9739866-8FE9-4166-9FE7-2D887148609A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lido Calorini
@ast
Lido Calorini
@en
Lido Calorini
@es
Lido Calorini
@nl
Lido Calorini
@sl
type
label
Lido Calorini
@ast
Lido Calorini
@en
Lido Calorini
@es
Lido Calorini
@nl
Lido Calorini
@sl
prefLabel
Lido Calorini
@ast
Lido Calorini
@en
Lido Calorini
@es
Lido Calorini
@nl
Lido Calorini
@sl
P106
P31
P496
0000-0002-5508-4200